Literature DB >> 6423544

Oxygen radical production by peritoneal macrophages and Kupffer cells elicited with Lactobacillus casei.

S Hashimoto, K Nomoto, T Matsuzaki, T Yokokura, M Mutai.   

Abstract

BALB/c mice were injected intraperitoneally (i.p.) or intravenously (i.v.) with Lactobacillus casei YIT9018 (LC 9018). The i.p. injected LC 9018 augmented oxygen radical (OR) production by peritoneal macrophages (PM) and suppressed the production of prostaglandin E2 by PM. The growth of i.p. inoculated Meth A fibrosarcoma was also inhibited by an i.p. injection of LC 9018. i.v. injection of LC 9018 stimulated OR production by fixed macrophages and inhibited the growth of Listeria monocytogenes in the liver. Furthermore, glucose-6-phosphate dehydrogenase activity in the liver was significantly increased (10 to 20 times) by LC 9018 i.v. injection. A significant correlation was observed between the augmentation of OR production by PM or fixed macrophages in the liver and inhibition of growth of Meth A or L. monocytogenes. The augmentation of OR production by LC 9018 was more marked and was maintained for a longer period of time than that by other bacterial immunostimulants.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6423544      PMCID: PMC263469          DOI: 10.1128/iai.44.1.61-67.1984

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  39 in total

1.  The role of superoxide anion generation in phagocytic bactericidal activity. Studies with normal and chronic granulomatous disease leukocytes.

Authors:  R B Johnston; B B Keele; H P Misra; J E Lehmeyer; L S Webb; R L Baehner; K V RaJagopalan
Journal:  J Clin Invest       Date:  1975-06       Impact factor: 14.808

2.  The viability of cells grown or centrifuged in a new density gradient medium, Percoll(TM).

Authors:  H Pertoft; K Rubin; L Kjellén; T C Laurent; B Klingeborn
Journal:  Exp Cell Res       Date:  1977-12       Impact factor: 3.905

3.  Oxygen-dependent microbial killing by phagocytes (first of two parts).

Authors:  B M Babior
Journal:  N Engl J Med       Date:  1978-03-23       Impact factor: 91.245

4.  Inhibition of tumor growth in vivo and in vitro by macrophages from rats treated with a streptococcal preparation, OK-432.

Authors:  Y Ishii; H Yamaoka; K Toh; K Kikuchi
Journal:  Gan       Date:  1976-02

5.  Biological defense mechanisms. The production by leukocytes of superoxide, a potential bactericidal agent.

Authors:  B M Babior; R S Kipnes; J T Curnutte
Journal:  J Clin Invest       Date:  1973-03       Impact factor: 14.808

6.  Three phases of phagocyte contribution to resistance against Listeria monocytogenes.

Authors:  M Mitsuyama; K Takeya; K Nomoto; S Shimotori
Journal:  J Gen Microbiol       Date:  1978-05

7.  Activated macrophages kill tumour cells by releasing arginase.

Authors:  G A Currie
Journal:  Nature       Date:  1978-06-29       Impact factor: 49.962

8.  Free radicals and inflammation: protection of synovial fluid by superoxide dismutase.

Authors:  J M McCord
Journal:  Science       Date:  1974-08-09       Impact factor: 47.728

9.  Mass isolation and culture of rat kupffer cells.

Authors:  A C Munthe-Kaas; T Berg; P O Seglen; R Seljelid
Journal:  J Exp Med       Date:  1975-01-01       Impact factor: 14.307

10.  An autopsy study of some routes of dissemination of cancer of the breast.

Authors:  E Viadana; I D Bross; J W Pickren
Journal:  Br J Cancer       Date:  1973-04       Impact factor: 7.640

View more
  14 in total

1.  Monoclonal antibodies to rat Kupffer cells. Anti-KCA-1 distinguishes Kupffer cells from other macrophages.

Authors:  S Sugihara; S R Martin; C K Hsuing; M Maruiwa; K J Bloch; R A Moscicki; A K Bhan
Journal:  Am J Pathol       Date:  1990-02       Impact factor: 4.307

2.  Augmentation of human blood monocyte microbicidal activity by RU 41740, a glycoprotein extract from Klebsiella pneumoniae.

Authors:  H Nielsen
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

3.  In vitro and in vivo release of cytostatic factors from Lactobacillus casei-elicited peritoneal macrophages after stimulation with tumor cells and immunostimulants.

Authors:  S Hashimoto; K Nomoto; M Nagaoka; T Yokokura
Journal:  Cancer Immunol Immunother       Date:  1987       Impact factor: 6.968

4.  Continuous infusion of Escherichia coli endotoxin in vivo primes in vitro superoxide anion release in rat polymorphonuclear leukocytes and Kupffer cells in a time-dependent manner.

Authors:  A M Mayer; J A Spitzer
Journal:  Infect Immun       Date:  1991-12       Impact factor: 3.441

5.  Correlation between increase in Ia-bearing macrophages and induction of T cell-dependent antitumor activity by Lactobacillus casei in mice.

Authors:  I Kato; T Yokokura; M Mutai
Journal:  Cancer Immunol Immunother       Date:  1988       Impact factor: 6.968

6.  Antimicrobial properties of Kupffer cells.

Authors:  G A Filice
Journal:  Infect Immun       Date:  1988-06       Impact factor: 3.441

7.  Protective effect of Lactobacillus casei on Pseudomonas aeruginosa infection in mice.

Authors:  S Miake; K Nomoto; T Yokokura; Y Yoshikai; M Mutai; K Nomoto
Journal:  Infect Immun       Date:  1985-05       Impact factor: 3.441

8.  Role of culture supernatant of cytotoxic/cytostatic macrophages in activation of murine resident peritoneal macrophages.

Authors:  S Hashimoto; M Nagaoka; K Hayashi; T Yokokura; M Mutai
Journal:  Cancer Immunol Immunother       Date:  1989       Impact factor: 6.968

9.  Inhibition of tumor metastasis of Lewis lung carcinoma in C57BL/6 mice by intrapleural administration of Lactobacillus casei.

Authors:  T Matsuzaki; T Yokokura
Journal:  Cancer Immunol Immunother       Date:  1987       Impact factor: 6.968

10.  Cytotoxic factor production by Kupffer cells elicited with Lactobacillus casei and Corynebacterium parvum.

Authors:  S Hashimoto; Y Seyama; T Yokokura; M Mutai
Journal:  Cancer Immunol Immunother       Date:  1985       Impact factor: 6.968

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.